Cargando…

Endocrine and targeted treatments for breast cancer

Detalles Bibliográficos
Autor principal:	Hudis, Clifford A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230533/ http://dx.doi.org/10.1186/bcr1823

Ejemplares similares

Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer
por: Ingle, James N
Publicado: (2008)

Integration of endocrine therapy with targeted agents
por: Johnston, Stephen RD
Publicado: (2008)

Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
por: Petridou, E, et al.
Publicado: (2000)

Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic
por: Martí, Covadonga, et al.
Publicado: (2020)

Markers of endocrine sensitivity
por: Hayes, Daniel F
Publicado: (2008)

Identification and mechanisms of endocrine resistance
por: Miller, William R
Publicado: (2008)

Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
por: Di Cosimo, Serena
Publicado: (2009)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Current and future choices in endocrine therapy
por: Ellis, Matthew
Publicado: (2007)

Intraoperative radiotherapy for breast cancer treatment efficiently targets the tumor bed preventing breast adipose stromal cell outgrowth
por: Uhlig, Stefanie, et al.
Publicado: (2020)

Personalized surgical treatment of breast cancer
por: Morrow, Monica
Publicado: (2007)

A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer
por: Shamash, J, et al.
Publicado: (2008)

Angiogenesis - still a worthwhile target for breast cancer therapy?
por: Lord, Simon, et al.
Publicado: (2010)

Do classical oestrogen markers predict for clinical response to endocrine therapy?
por: Miller, William R
Publicado: (2007)

Metabolic approaches to breast cancer treatment and prevention
por: Howell, Anthony
Publicado: (2007)

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
por: Newcomb, P A, et al.
Publicado: (2010)

The evolution of treatment for early breast cancer: what’s next?
por: Howell, T
Publicado: (2009)

The emerging breast cancer epidemic: early diagnosis and treatment
por: Howell, Anthony
Publicado: (2010)

Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?
por: Smith, Ian E
Publicado: (2009)

A novel MEN1 pathogenic variant in an Italian patient with multiple endocrine neoplasia type 1
por: Corsello, Andrea, et al.
Publicado: (2020)

Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target
por: Richard, François, et al.
Publicado: (2023)

Breast cancer treatment in clinical practice compared to best evidence and practice guidelines
por: Bloom, B S, et al.
Publicado: (2004)

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
por: Keim-Malpass, Jessica, et al.
Publicado: (2018)

CD70: A Potential Target in Breast Cancer?
por: Petrau, Camille, et al.
Publicado: (2014)

Breast tumour stroma is a prognostic indicator and target for therapy
por: Howell, Anthony, et al.
Publicado: (2009)

Sleep duration and breast cancer risk in the Breast Cancer Detection Demonstration Project follow-up cohort
por: Qian, X, et al.
Publicado: (2015)

Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer
por: Tabar, László, et al.
Publicado: (2008)

Left-handedness and risk of breast cancer
por: Fritschi, L, et al.
Publicado: (2007)

Reflections from a breast surgeon with breast cancer on how to improve cancer care
por: O’Riordan, Elizabeth Louise
Publicado: (2019)

Oestrogen is bad for patients with breast cancer?
por: Jordan, V Craig, et al.
Publicado: (2007)

Assessing risk for breast cancer
por: Cuzick, Jack
Publicado: (2008)

Radiation impact in breast cancer
por: Ragaz, Joseph
Publicado: (2009)

Birth weight and breast cancer risk
por: Troisi, R, et al.
Publicado: (2006)

Enhertu (Fam-trastuzumab-deruxtecan-nxki) – Revolutionizing treatment paradigm for HER2-Low breast cancer
por: Siddiqui, Tasmiyah, et al.
Publicado: (2022)

Breast cancer survival and prognosis by screening history
por: Coldman, A J, et al.
Publicado: (2014)

Breast Cancer Screening in High-Risk Women
por: Brekelmans, C. T. M., et al.
Publicado: (1999)

Underutilisation of breast cancer prevention medication in Australia
por: Macdonald, Courtney, et al.
Publicado: (2021)

Is anti-hormonal treatment in DCIS of the breast a need?
por: Tjalma, WAA
Publicado: (2016)

Detection of Toxoplasma gondii DNA in Malignant Breast Tissues in Breast Cancer Patients
por: Kalantari, Narges, et al.
Publicado: (2017)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Houssami, Nehmat
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mlk78ljoh8l06hcfg0lqpscsu9